Search
Search Results
##search.searchResults.foundPlural##
-
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3772PDF: 1281HTML: 3917Untitled: 248Untitled: 282 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2409PDF: 1205HTML: 988 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2450PDF: 1699HTML: 458 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3303PDF: 1369HTML: 4148 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1053PDF: 492HTML: 133 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1781PDF: 1226HTML: 320 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2443PDF: 1022HTML: 1656Fig 1: 204Tab I: 228Cover Letter: 224 -
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN
2912PDF: 890HTML: 1162Cover: 196 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2276PDF: 1000HTML: 1978 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3346PDF: 1575HTML: 473 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3838PDF: 1328HTML: 853Figure 2: 475Figure 1: 3155 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1698PDF: 624HTML: 281 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
3091PDF: 638Suppl. Files: 299HTML: 267 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
4574PDF: 1052HTML: 475TABLE: 204FIGURES: 273 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3253PDF: 1137HTML: 1873 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
979PDF: 541HTML: 219 -
How I treat acute and persistent sickle cell pain
2037PDF: 1145HTML: 648 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2176PDF: 1343HTML: 3509 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1068PDF: 725HTML: 270 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3255PDF: 1202HTML: 486 -
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
158PDF: 144HTML: 42 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3131PDF: 903HTML: 7293Kost Fig1: 206Kost Fig 2: 194Kost Fig3: 196Kost Fig 4: 209Kost Fig5: 209Kost fig 6: 194







